| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |